See also this year's filing and all EDGAR filings for this company.
PDF Report 0001796129_2024_Vincerx_Pharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001796129, Vincerx Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 14,733,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 125,000 |
| 3 | remainder_Assets | 3,359,000 |
| 4 | LiabilitiesCurrent | 5,605,000 |
| 5 | LiabilitiesNoncurrent | 1,390,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,363,840 |
| 9 | ResearchAndDevelopmentExpense | 20,199,004 |
| 10 | remainder_Expenses | 2,410,096 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,932,860 |
| 13 | remainder_ComprehensiveNetIncome | 61,116 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 18,217,000 |
| 1 | Liabilities | 6,995,000 |
| 2 | Expenses | 35,972,940 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 11,222,000 |
| 5 | NetIncome | -32,040,080 |
| 6 | ComprehensiveNetIncome | -32,009,522 |
| 7 | BaseVar | 32,589,458 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.599 |
| 9 | EconomicCapitalRatio | 1.37 |